Glucagon increases beating rate but not contractility in rat right atrium. comparison with isoproterenol

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Merino, Beatriz ^a,b   Quesada, Ivan ^a,b   Hernández Cascales, Jesús ^c  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON; GLUCAGON RECEPTOR; ISOPRENALINE; MESSENGER RNA; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PROTEIN KINASE C; RYANODINE RECEPTOR; CARBAZOLE DERIVATIVE; ICI D2788; ISOQUINOLINE DERIVATIVE; KT 5720; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHRONOTROPISM; CONTROLLED STUDY; DRUG RESPONSE; ENZYME INHIBITION; GENE EXPRESSION; GLUCAGON RECEPTOR GENE; HEART BEAT; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT ATRIUM; MALE; NONHUMAN; OUTCOME ASSESSMENT; RAT; RECEPTOR GENE; SARCOPLASMIC RETICULUM; SINUS NODE; ANIMAL; ANTAGONISTS AND INHIBITORS; CALCIUM SIGNALING; CARDIAC MUSCLE; COMPARATIVE STUDY; DRUG EFFECTS; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART CONTRACTION; HEART RATE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ATRIAL FUNCTION, RIGHT; CALCIUM SIGNALING; CARBAZOLES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCAGON; HEART ATRIA; HEART RATE; ISOPROTERENOL; ISOQUINOLINES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHODIESTERASE 3 INHIBITORS; PHOSPHODIESTERASE 4 INHIBITORS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 84941793741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132884     Document Type: Article

References (42)

1. White CM (1999) A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol 39: 442-447. PMID: 10234590.
2. DeWitt CR, Waksman JC (2004) Pharmacology, pathophysiology and management of calcium channel blocker and β-blocker toxicity. Toxicol Rev 23: 223-238. PMID: 15898828.
3. MacLeod KM, Rodgers R, MacNeill JH (1981) Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparations of rat and guinea pig. J Pharmacol Exp Ther 217: 798-804. PMID: 6262497.
4. Juan-Fita MJ, Vargas ML, Hernández J (2005) The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium. Eur J Pharmacol 512: 207-213. PMID: 15840406.
5. Gonzalez-Muñoz C, Nieto-Cerón S, Cabezas-Herrera J, Hernández-Cascales J (2008) Glucagon increases contractility in ventricle but not in atrium of the rat heart. Eur J Pharmacol 587: 243-247. doi:10.1016/j.ejphar.2008.04.001 PMID: 18474367.
6. Antonaccio MJ, Cavaliere T (1974) A comparison of the effects of some inotropic and chronotropic agents on isolated atria from normotensive (NTR) and spontaneously hypertensive (SHR) rats. Arch int Pharmacodyn 209: 273-282. PMID: 4216310.
7. Furukawa Y, Saegusa K, Ogiwara Y, Chiba S (1986) Different effectiveness of glucagons on the pacemaker activity and contractility in intact dog hearts and in isolated perfused right atria. Jpn. Heart J 27: 215-222. PMID: 3723799.
8. Rodgers RL (2012) Glucagon and cyclic AMP: Time to turn out the page?. Curr Diabetes Rev 8: 362- 381. PMID: 22587514.
9. Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520. PMID: 16968949.
10. Monfredi O, Dobrzynski H, Mondal T, Boyett MR, Morris GM (2010) The anatomy and physiology of the Sinoatrial Node- A contemporary Review. PACE 33: 1392-1406. doi:10.1111/j.1540-8159.2010.02838.x PMID: 20946278.
11. DiFrancesco D (2010) The role of the funny current in pacemaker activity. Circ Res 106: 434-446. doi:10.1161/CIRCRESAHA.109.208041 PMID: 20167941.
12. Wahl-Schott C, Fenske S, Biel M (2014) HCN channels: new roles in sinoatrial node function. Curr Opin Pharmacol 15: 83-90. doi:10.1016/j.coph.2013.12.005 PMID: 24441197.
13. Vinogradova TM, Lakatta EG (2009) Regulation of basal and reserve cardiac pscemaker function by interactions of cAMP-mediated PKA-dependent Ca+2 cycling with surface membrane channels. J Mol Cell Pharmacol 47: 456-474.
14. Gloerich M, Bos JL (2010) Epac: Defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 50: 355-375. doi:10.1146/annurev.pharmtox.010909.105714 PMID: 20055708.
15. Vinogradova TM, Sirenko S, Lyashkov AE, Younes A, Li Y, Zu W, et al. (2008) Constitutive phosphodiesterase activity restricts spontaneous beating rate of cardiac pacemaker cells by suppressing local Ca+2 release. Circ Res 102:761-769. doi:10.1161/CIRCRESAHA.107.161679 PMID: 18276917.
16. Brodde OE, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51: 651-689. PMID: 10581327.
17. Hardouin S, Bourgeois F, Toraasson M, Oubenaissa A, Elalouf JM, Fellmann D, et al. (1998) β-Adrenergic and muscarinic receptor mRNA accumulation in the sinoatrial node area of adult and senescent rat hearts. Mech Ageing Dev 100: 277-297. PMID: 9578116.
18. BoSmith RE, Briggs I, Sturgess NC (1993) Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells. Br J Pharmacol 110: 343-349. PMID: 7693281.
19. Ma J (1993) Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle. J Gen Physiol 102: 1031-1056. PMID: 7510773.
20. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, et al. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436-440. PMID: 3028414.
21. Lochner A, Moolman JA (2006) The many faces of H-89: a review. Cardiovasc Drug Rev 24: 261-274. PMID: 17214602.
22. Kobayashi E, Nakano H, Morimoto M, Tamaoki T (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Bioph Res Co 159: 548-553.
23. Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H (1990) KN-62, 1-[N, O-bis(5- isoquinolinesufonyl)-N-methyl-L-tyrosyl]-4-phenylpipeazine, a specific inhibitor of Ca2+/calmodilindependent protein kinase II. J Biol Chem 265: 4315-4320. PMID: 2155222.
24. Asada M, Endou M (2001) Possible involvement of cyclic adenosine monophosphate-independent mechanism in the positive chronotropic effect of norepinephrine in the isolated guinea pig right atrium. Anesthesiology 95: 437-444. PMID: 11506118.
25. Du XJ, Feng X, Gao XM, Tan TP, Kiriazis H, Dart AM (2004) If channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br J Pharmacol 142: 107-112. PMID: 15066901.
26. Guth BD, Dietze T (1995) If current mediates β-adrenergic enhancement of heart rate but not contractility in vivo. Basic Res Cardiol 90: 192-202. PMID: 7575372.
27. Rochais F, Abi-Gerges A, Horner K, Lefebvre F, Cooper DMF, Conti M, et al. (2006) A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ Res 98: 1081-1088. PMID: 16556871.
28. Song GL, Tang M, Liu CJ, Luo HY, Liang HM, Hu XW, et al. (2002) Developmental changes in functional expression and β-adrenergic regulation of If in the heart of mouse embryo. Cell Res 12: 385- 394. PMID: 12528896.
29. Liao Z, Lockhead D, Larson ED, Proenza C (2010) Phosphorilation and modulation of hyperpolarization- activated HCN4 channels by protein kinase A in the mouse sinoatrial node. J Gen Physiol 136: 247-258. doi:10.1085/jgp.201010488 PMID: 20713547.
30. Ozcan L, Wong CL, Li G, Xu T, Pajvani U (2012) Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metabolism 15: 739-751. doi:10.1016/j.cmet.2012.03.002 PMID: 22503562.
31. Mongillo M, McSorley T, Evellin S, Sood A, Lissandron V, Terrin A, et al. (2004) Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartimentalized phosphodiesterases. Circ Res 95: 67-75. PMID: 15178638.
32. Leroy J, Abi-Gerges A, Nikolaev VO, Richter W, Lechene P, Mazet JL, et al. (2008) Spatiotemporal dynamics of β-adrenergic cAMP signals and L-type Ca+2 channel regulation in adult rat ventricular myocytes. Circ Res 102: 1091-1100. doi:10.1161/CIRCRESAHA.107.167817 PMID: 18369156.
33. Shahid M, Rodger IW (1989) Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition. Br J Pharmacol 98:291-301. PMID: 2478244.
34. Stevenson LW (2003) Clinical use of inotropic therapy for heart failure: looking backward or forward?. Circulation 108: 367-372. PMID: 12876135.
35. London JA, Sena MJ (2006) Pharmacologic support of the failing heart. Surg Clin N Am 86: 1503- 1521. PMID: 17116460.
36. Nord HJ, Fontanes AL, Williams JF (1970) Treatment of congestive heart failure with glucagon. Ann Intern Med 72: 649-653. PMID: 4915149.
37. Love JN, Howell JM (1997) Glucagon therapy in the treatment of symptomatic bradycardia. Ann Emerg Med 29: 181-183. PMID: 8998104.
38. Love JN, Sachdeva DK, Bessman ES, Curtis LA, Howell JM (1998) A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. Chest 114: 323-326. PMID: 9674488.
39. Bindon MJ, Barlotta K (2009) Glucagon treatment for bradycardia and a junctional rhythm caused by excessive beta-blockade. Resuscitation 80: 1327. doi:10.1016/j.resuscitation.2009.08.002 PMID: 19744763.
40. Matsuda Y, Toma T, Ogawa H, Matsuzaki M, Katayama K, Fujii T, et al. (1983) Importance of the left atrial function in patients with myocardial infarction. Circulation 67: 565-571.
41. Prasad K (1975) Electrophysiologic effects of glucagon on human cardiac muscle. Clin Pharmacol Ther 18: 22-30. PMID: 1149358.
42. Jesse R, Schneider KW, Deeg P (1975) The effect of intravenous infusion of glucagon on the contractility of the left ventricular myocardium in man. Basic Res Cardiol 70: 217-226. PMID: 1137561.